Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd. (300501.SZ)
CNY 14.24
(1.28%)
CNY 14.24
(1.28%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.02 Billion CNY | 63.54% |
| 2022 | 625.79 Million CNY | -7.77% |
| 2021 | 678.54 Million CNY | 28.25% |
| 2020 | 529.08 Million CNY | 11.98% |
| 2019 | 472.49 Million CNY | 107.56% |
| 2018 | 227.64 Million CNY | 198.8% |
| 2017 | 76.18 Million CNY | -14.85% |
| 2016 | 89.46 Million CNY | 31.74% |
| 2015 | 67.91 Million CNY | 21.48% |
| 2014 | 55.9 Million CNY | -8.7% |
| 2013 | 61.23 Million CNY | 10.41% |
| 2012 | 55.45 Million CNY | -1.65% |
| 2011 | 56.38 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1 Billion CNY | -1.57% |
| 2024 Q2 | 1 Billion CNY | 0.07% |
| 2024 Q3 | 1.01 Billion CNY | 1.14% |
| 2023 Q2 | 1 Billion CNY | -8.32% |
| 2023 FY | 1.02 Billion CNY | 63.54% |
| 2023 Q4 | 1.02 Billion CNY | 4.45% |
| 2023 Q1 | 1.1 Billion CNY | 75.85% |
| 2023 Q3 | 979.84 Million CNY | -2.88% |
| 2022 Q2 | 743.82 Million CNY | 6.67% |
| 2022 FY | 625.79 Million CNY | -7.77% |
| 2022 Q4 | 625.79 Million CNY | -11.46% |
| 2022 Q3 | 706.76 Million CNY | -4.98% |
| 2022 Q1 | 697.32 Million CNY | 2.77% |
| 2021 Q1 | 603.12 Million CNY | 13.99% |
| 2021 FY | 678.54 Million CNY | 28.25% |
| 2021 Q3 | 653.24 Million CNY | 3.93% |
| 2021 Q4 | 678.54 Million CNY | 3.87% |
| 2021 Q2 | 628.52 Million CNY | 4.21% |
| 2020 FY | 529.08 Million CNY | 11.98% |
| 2020 Q4 | 529.08 Million CNY | 18.02% |
| 2020 Q3 | 448.3 Million CNY | 10.93% |
| 2020 Q2 | 404.12 Million CNY | -16.17% |
| 2020 Q1 | 482.05 Million CNY | 2.02% |
| 2019 Q2 | 399.56 Million CNY | 15.94% |
| 2019 Q1 | 344.64 Million CNY | 51.4% |
| 2019 FY | 472.49 Million CNY | 107.56% |
| 2019 Q3 | 426.21 Million CNY | 6.67% |
| 2019 Q4 | 472.49 Million CNY | 10.86% |
| 2018 Q2 | 109.63 Million CNY | 14.47% |
| 2018 Q1 | 95.78 Million CNY | 25.72% |
| 2018 FY | 227.64 Million CNY | 198.8% |
| 2018 Q4 | 227.64 Million CNY | 24.74% |
| 2018 Q3 | 182.49 Million CNY | 66.45% |
| 2017 Q4 | 76.18 Million CNY | 11.15% |
| 2017 Q2 | 72.95 Million CNY | -5.66% |
| 2017 FY | 76.18 Million CNY | -14.85% |
| 2017 Q3 | 68.54 Million CNY | -6.05% |
| 2017 Q1 | 77.33 Million CNY | -13.56% |
| 2016 Q4 | 89.46 Million CNY | 25.49% |
| 2016 FY | 89.46 Million CNY | 31.74% |
| 2016 Q2 | 65.62 Million CNY | 14.4% |
| 2016 Q3 | 71.29 Million CNY | 8.65% |
| 2016 Q1 | 57.36 Million CNY | -15.53% |
| 2015 Q4 | 67.91 Million CNY | -0.37% |
| 2015 Q3 | 68.16 Million CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 FY | 67.91 Million CNY | 21.48% |
| 2014 FY | 55.9 Million CNY | -8.7% |
| 2013 FY | 61.23 Million CNY | 10.41% |
| 2012 FY | 55.45 Million CNY | -1.65% |
| 2011 FY | 56.38 Million CNY | 0.0% |